ArticleMolecular therapy. Oncology2026

TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer.

Audrey Merienne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.